RESIN-LESS
CHROMATOGRAPHY

Increase productivity with fast, high volume, cost-effective purification of biologics using membrane technology

 

Purilogics has developed a completely new way to manage the chromatography capture, polishing, and production of therapeutics.

 

Purexa™ chromatography membranes achieve high production volumes with rapid changeover and consistent performance

Purexa™ Membranes can produce 10x more, with faster flow rates, no incubation periods, all with easier set up and tear down, with consistency of production and longevity of results when compared to resins. This solution performs while it reduces production stressors and concerns.

We help get biologics to market, fast.

 

Life Science evolves.
Donaldson Solves.

Purilogics is part of Donaldson and its focus on Life Sciences and Bioprocessing. Learn more 🡒

 
 

Scientific Validation & Case Studies of Purexa™

Featured
Addressing the Plasmid DNA Manufacturing Bottleneck
Addressing the Plasmid DNA Manufacturing Bottleneck

Over the past few years, we have seen a steady increase in the demand for plasmid DNA, as the gene and cell therapy industries have experienced rapid growth…

Read More →
How Does Flow Rate Affect the Binding Capacity of Purexa™ Membranes?
How Does Flow Rate Affect the Binding Capacity of Purexa™ Membranes?

At Purilogics, we take pride in designing and developing membrane chromatography technologies for biologics purification. Our mission is to provide rapid and effective purification solutions to help the biopharmaceutical industry simplify biologics purification.

Read More →
Purexa™ PrA mini - Fast Antibody Purification within 1 Minute
Purexa™ PrA mini - Fast Antibody Purification within 1 Minute

Purexa™ PrA mini is designed for rapid processing of small quantity of antibodies, especially at low titers. During elution, the first 0.5 mL was discarded. As is shown in the fitures, a majority of the antibody was eluted in the second 0.5 mL elution fraction, which had a concentration of 3.3 mg/mL and was corresponding to a recovery of 78%.

Read More →